Clinical Trial: Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Observational - CRKL Expression at the Protein Level in Rhabdomyosarcoma Tumors by Tissue Microarray (TMA)

Brief Summary: This research trial studies biomarkers in tumor tissue samples from younger patients with rhabdomyosarcoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer

Detailed Summary:

PRIMARY OBJECTIVES:

I. To demonstrate CRKL expression at the protein level in rhabdomyosarcoma tumors by tissue microarray (TMA).

OUTLINE:

Archived tumor tissue samples are analyzed for CRKL expression.

Sponsor: Children's Oncology Group

Current Primary Outcome: CRKL expression at the protein level [ Time Frame: 1 month ]

Original Primary Outcome: CRKL expression at the protein level

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Children's Oncology Group

Dates:
Date Received: December 16, 2011
Date Started: December 2011
Date Completion:
Last Updated: May 17, 2016
Last Verified: May 2016